News

Frimley Health NHS Foundation Trust has recruited its first patient for a weekly injection to tackle thyroid eye disease.
LEXINGTON, Mass. and AMSTERDAM, April 17, 2025 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical ...
People with orbital cellulitis may have a bulging eye and pain when moving ... National Eye Institute. Graves' eye disease. American Kidney Fund. Nephrotic syndrome treatments, causes & symptoms.
A new biotech, Merida Biosciences, has launched with $121 million in the bank to advance a new class of precision treatments for autoimmune and ... With its lead program, Merida is targeting Graves’ ...
Treatments can only help to ease symptoms and limit complications. The WHO recommends rest, keeping hydrated with fluids, and using fever reducers such as ibuprofen or acetaminophen. Antibiotics can ...
Introduction: Graves´ disease (GD) is the predominant cause of hyperthyroidism. Treatment options include antithyroid drugs (ATD), surgery, and radioactive iodine ablation (RI). Although thyroid ...
These supports will aid Aurion's development of AURN001, a treatment for corneal edema, or swelling of the cornea, which can occur as a secondary effect of corneal endothelial disease. Aurion ...
The diagnosis of Graves' disease in pregnancy can be complex because ... A balance must be made in optimizing treatment for one without impinging on the other. Iodide has not been recommended ...
type TTR, addressing the underlying cause of the disease. It is approved for the treatment of the polyneuropathy of hereditary transthyretin-mediated amyloidosis (hATTR-PN) in adults. HELIOS-B was a ...